S&P 500   4,513.04 (-1.18%)
DOW   34,022.04 (-1.34%)
QQQ   388.10 (-1.45%)
AAPL   165.01 (-0.18%)
MSFT   330.61 (+0.01%)
FB   311.21 (-4.08%)
GOOGL   2,824.84 (-0.46%)
AMZN   3,450.09 (-1.62%)
TSLA   1,098.27 (-4.06%)
NVDA   315.15 (-3.55%)
BABA   122.49 (-3.95%)
NIO   38.37 (-1.94%)
CGC   9.95 (-7.10%)
AMD   149.58 (-5.55%)
GE   93.11 (-1.98%)
MU   85.26 (+1.50%)
T   22.23 (-2.63%)
F   19.58 (+2.03%)
DIS   142.24 (-1.84%)
PFE   54.73 (+1.86%)
AMC   28.57 (-15.82%)
ACB   6.02 (-6.23%)
BA   188.26 (-4.85%)
S&P 500   4,513.04 (-1.18%)
DOW   34,022.04 (-1.34%)
QQQ   388.10 (-1.45%)
AAPL   165.01 (-0.18%)
MSFT   330.61 (+0.01%)
FB   311.21 (-4.08%)
GOOGL   2,824.84 (-0.46%)
AMZN   3,450.09 (-1.62%)
TSLA   1,098.27 (-4.06%)
NVDA   315.15 (-3.55%)
BABA   122.49 (-3.95%)
NIO   38.37 (-1.94%)
CGC   9.95 (-7.10%)
AMD   149.58 (-5.55%)
GE   93.11 (-1.98%)
MU   85.26 (+1.50%)
T   22.23 (-2.63%)
F   19.58 (+2.03%)
DIS   142.24 (-1.84%)
PFE   54.73 (+1.86%)
AMC   28.57 (-15.82%)
ACB   6.02 (-6.23%)
BA   188.26 (-4.85%)
S&P 500   4,513.04 (-1.18%)
DOW   34,022.04 (-1.34%)
QQQ   388.10 (-1.45%)
AAPL   165.01 (-0.18%)
MSFT   330.61 (+0.01%)
FB   311.21 (-4.08%)
GOOGL   2,824.84 (-0.46%)
AMZN   3,450.09 (-1.62%)
TSLA   1,098.27 (-4.06%)
NVDA   315.15 (-3.55%)
BABA   122.49 (-3.95%)
NIO   38.37 (-1.94%)
CGC   9.95 (-7.10%)
AMD   149.58 (-5.55%)
GE   93.11 (-1.98%)
MU   85.26 (+1.50%)
T   22.23 (-2.63%)
F   19.58 (+2.03%)
DIS   142.24 (-1.84%)
PFE   54.73 (+1.86%)
AMC   28.57 (-15.82%)
ACB   6.02 (-6.23%)
BA   188.26 (-4.85%)
S&P 500   4,513.04 (-1.18%)
DOW   34,022.04 (-1.34%)
QQQ   388.10 (-1.45%)
AAPL   165.01 (-0.18%)
MSFT   330.61 (+0.01%)
FB   311.21 (-4.08%)
GOOGL   2,824.84 (-0.46%)
AMZN   3,450.09 (-1.62%)
TSLA   1,098.27 (-4.06%)
NVDA   315.15 (-3.55%)
BABA   122.49 (-3.95%)
NIO   38.37 (-1.94%)
CGC   9.95 (-7.10%)
AMD   149.58 (-5.55%)
GE   93.11 (-1.98%)
MU   85.26 (+1.50%)
T   22.23 (-2.63%)
F   19.58 (+2.03%)
DIS   142.24 (-1.84%)
PFE   54.73 (+1.86%)
AMC   28.57 (-15.82%)
ACB   6.02 (-6.23%)
BA   188.26 (-4.85%)
NASDAQ:NLTX

Neoleukin Therapeutics SEC Filings & 10K Form

$4.88
-0.48 (-8.96%)
(As of 12/1/2021 03:55 PM ET)
Add
Compare
Today's Range
$4.87
$5.42
50-Day Range
$4.91
$7.75
52-Week Range
$4.66
$17.95
Volume
5,477 shs
Average Volume
210,300 shs
Market Capitalization
$207.05 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.95

Neoleukin Therapeutics (NASDAQ:NLTX) SEC Filings

DateFilerForm TypeView
08/26/2021
6:08 PM
DRACHMAN JONATHAN G (Reporting)
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2021
8:46 PM
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Walkey Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2021
4:22 PM
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Walkey Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2021
4:07 PM
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Walkey Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2021
4:06 PM
DRACHMAN JONATHAN G (Reporting)
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2021
7:00 AM
Neoleukin Therapeutics, Inc. (Filer)
Neoleukin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/26/2021
6:37 PM
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Walkey Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2021
4:24 PM
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Walkey Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2021
7:09 AM
Neoleukin Therapeutics, Inc. (Filer)
Neoleukin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/12/2021
7:53 PM
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Walkey Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2021
7:07 AM
Neoleukin Therapeutics, Inc. (Filer)
Neoleukin Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/12/2021
7:04 AM
Neoleukin Therapeutics, Inc. (Filer)
Neoleukin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2021
4:28 PM
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Walkey Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2021
3:33 PM
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Patel Priti (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/30/2021
4:52 PM
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Walkey Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2021
6:59 PM
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Walkey Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2021
4:11 PM
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Walkey Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2021
6:08 PM
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Walkey Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2021
6:06 PM
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Walkey Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/06/2021
7:37 PM
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Walkey Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2021
4:21 PM
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Walkey Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2021
4:21 PM
Neoleukin Therapeutics, Inc. (Filer)
Neoleukin Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/24/2021
5:48 PM
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Walkey Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2021
7:45 PM
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Walkey Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2021
7:44 PM
Ho Robert (Reporting)
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2021
5:52 PM
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Walkey Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2021
7:17 PM
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Walkey Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2021
3:20 PM
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Walkey Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2021
3:25 PM
Neoleukin Therapeutics, Inc. (Subject)
Neoleukin Therapeutics (Subject)
Silva Manzano Daniel Adriano (Filed by)
Form SC 13G
02/12/2021
3:23 PM
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Walkey Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2021
3:51 PM
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Walkey Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2021
3:11 PM
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Walkey Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2021
8:14 AM
Neoleukin Therapeutics, Inc. (Filer)
Neoleukin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2020
6:31 PM
667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2020
4:11 PM
BAKER BROS. ADVISORS LP (Filed by)
Neoleukin Therapeutics, Inc. (Subject)
Neoleukin Therapeutics (Subject)
Form SC 13D/A
12/21/2020
11:15 PM
Neoleukin Therapeutics, Inc. (Filer)
Neoleukin Therapeutics (Filer)
Form EFFECT
12/11/2020
3:02 PM
Neoleukin Therapeutics, Inc. (Filer)
Neoleukin Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
12/01/2020
3:01 PM
Neoleukin Therapeutics, Inc. (Filer)
Neoleukin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2020
7:06 AM
Neoleukin Therapeutics, Inc. (Filer)
Neoleukin Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/09/2020
7:00 AM
Neoleukin Therapeutics, Inc. (Filer)
Neoleukin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/20/2020
5:15 PM
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Vance Holly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/20/2020
5:14 PM
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Vance Holly (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/10/2020
3:28 PM
Babler Martin (Reporting)
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2020
3:23 PM
Babler Martin (Reporting)
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/12/2020
3:10 PM
Ho Robert (Reporting)
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2020
4:11 PM
Neoleukin Therapeutics, Inc. (Filer)
Neoleukin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2020
3:09 PM
Neoleukin Therapeutics, Inc. (Filer)
Neoleukin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2020
3:12 PM
Neoleukin Therapeutics, Inc. (Filer)
Neoleukin Therapeutics (Filer)
Form 424B5
06/02/2020
3:30 PM
Lavelle Erin M. (Reporting)
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2020
3:29 PM
Lavelle Erin M. (Reporting)
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/01/2020
7:31 AM
Neoleukin Therapeutics, Inc. (Filer)
Neoleukin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2020
3:28 PM
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Williams Lewis T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2020
3:27 PM
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
SIMPSON TODD E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2020
3:26 PM
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Noonberg Sarah B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2020
3:01 PM
Neoleukin Therapeutics, Inc. (Filer)
Neoleukin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2020
7:04 AM
Neoleukin Therapeutics, Inc. (Filer)
Neoleukin Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/06/2020
6:45 AM
Neoleukin Therapeutics, Inc. (Filer)
Neoleukin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/13/2020
7:30 AM
Neoleukin Therapeutics, Inc. (Filer)
Neoleukin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/06/2020
6:04 PM
Green Jeremy (Reporting)
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Redmile Group, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/06/2020
6:03 PM
Green Jeremy (Reporting)
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Redmile Group, LLC (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/24/2020
7:33 AM
Neoleukin Therapeutics, Inc. (Filer)
Neoleukin Therapeutics (Filer)
Form DEFA14A
03/24/2020
7:31 AM
Neoleukin Therapeutics, Inc. (Filer)
Neoleukin Therapeutics (Filer)
Form DEF 14A
03/16/2020
8:39 PM
Ho Robert (Reporting)
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2020
8:38 PM
Ho Robert (Reporting)
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/12/2020
3:06 PM
Neoleukin Therapeutics, Inc. (Filer)
Neoleukin Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/10/2020
7:31 AM
Neoleukin Therapeutics, Inc. (Filer)
Neoleukin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/25/2020
7:16 AM
Neoleukin Therapeutics, Inc. (Filer)
Neoleukin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2020
7:32 AM
Neoleukin Therapeutics, Inc. (Filer)
Neoleukin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/30/2019
3:31 PM
Neoleukin Therapeutics, Inc. (Filer)
Neoleukin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2019
4:15 PM
DRACHMAN JONATHAN G (Filed by)
Neoleukin Therapeutics, Inc. (Subject)
Neoleukin Therapeutics (Subject)
Form SC 13D
12/27/2019
4:03 PM
EcoR1 Capital, LLC (Filed by)
Neoleukin Therapeutics, Inc. (Subject)
Neoleukin Therapeutics (Subject)
Form SC 13G
12/20/2019
5:53 PM
DRACHMAN JONATHAN G (Reporting)
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2019
4:17 PM
BAKER BROS. ADVISORS LP (Filed by)
Neoleukin Therapeutics, Inc. (Subject)
Neoleukin Therapeutics (Subject)
Form SC 13D/A
12/20/2019
4:16 PM
667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2019
7:43 PM
Neoleukin Therapeutics, Inc. (Filer)
Neoleukin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2019
4:38 PM
Neoleukin Therapeutics, Inc. (Filer)
Neoleukin Therapeutics (Filer)
Form 424B5
12/17/2019
3:43 PM
Neoleukin Therapeutics, Inc. (Filer)
Neoleukin Therapeutics (Filer)
Form 424B5
12/17/2019
3:38 PM
Neoleukin Therapeutics, Inc. (Filer)
Neoleukin Therapeutics (Filer)
Form 8-K/A
12/05/2019
7:30 AM
Neoleukin Therapeutics, Inc. (Filer)
Neoleukin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2019
4:16 PM
BAKER BROS. ADVISORS LP (Filed by)
Neoleukin Therapeutics, Inc. (Subject)
Neoleukin Therapeutics (Subject)
Form SC 13D/A
11/15/2019
3:32 PM
Neoleukin Therapeutics, Inc. (Filer)
Neoleukin Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/13/2019
8:03 AM
Neoleukin Therapeutics, Inc. (Filer)
Neoleukin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2019
8:02 AM
Neoleukin Therapeutics, Inc. (Filer)
Neoleukin Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/15/2019
4:19 PM
667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2019
3:48 PM
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
SIMPSON TODD E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2019
3:45 PM
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Noonberg Sarah B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2019
3:45 PM
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Nolan Sean P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2019
3:44 PM
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Williams Lewis T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/11/2019
7:34 AM
Neoleukin Therapeutics, Inc. (Filer)
Neoleukin Therapeutics (Filer)
Form 8-K/A
10/02/2019
3:15 PM
Neoleukin Therapeutics, Inc. (Filer)
Neoleukin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2019
7:38 AM
Neoleukin Therapeutics, Inc. (Filer)
Neoleukin Therapeutics (Filer)
Form DEFA14A
10/02/2019
7:36 AM
Neoleukin Therapeutics, Inc. (Filer)
Neoleukin Therapeutics (Filer)
Form DEF 14A
09/20/2019
7:31 AM
Neoleukin Therapeutics, Inc. (Filer)
Neoleukin Therapeutics (Filer)
Form PRE 14A
09/13/2019
6:18 PM
DRACHMAN JONATHAN G (Reporting)
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Form 4/A
09/11/2019
4:39 PM
DRACHMAN JONATHAN G (Reporting)
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2019
3:48 PM
DRACHMAN JONATHAN G (Reporting)
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2019
2:58 PM
Boyd Meta Cantey (Reporting)
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/13/2019
4:08 PM
BAKER BROS. ADVISORS LP (Filed by)
Neoleukin Therapeutics, Inc. (Subject)
Neoleukin Therapeutics (Subject)
Form SC 13D/A
08/12/2019
4:54 PM
DRACHMAN JONATHAN G (Reporting)
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2019
4:53 PM
Neoleukin Therapeutics, Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Williams Lewis T (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
This page was last updated on 12/1/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.